Investment group SV Life Sciences said today it is rebranding to SV Health Investors. The Boston-based company said the new moniker will “better reflect the firm’s longstanding strategy and multi-sector focus.” The investment group said it targets early-stage opportunities in biotechnology, early-stage and revenue stage medical device opportunities and growth equity investments in later-stage businesses in healthcare […]
SV Life Sciences gets in on ‘significant’ round for Bardy Diagnostics
Healthcare investor SV Life Sciences joined a ‘significant round of growth capital’ for medtech developer Bardy Diagnostics and its Carnation cardiac monitor and arrhythmia detection device. The Charlotte, N.C.-based company’s Carnation ambulatory monitor is a non-invasive P-wave centric ambulatory cardiac monitor and arrhythmia detection device which the company touts as the world’s smallest and lightest […]
SV Life Sciences’ 6th fund pulls in $274m
SV Life Sciences said it raised $274 million of the $400 million it hopes to put into its 6th fund for investing in healthcare companies. The Boston-based venture capital shop said in a regulatory filing that 24 unnamed investors participated in the round, which began in May 2015. SV Life Sciences, which has some $1.9 billion […]
Direct Flow Medical raises a $32 million in funding round | Medtech funding for the week of December 1, 2014
TAVI: Direct Flow Medical raises $32m, names 1st CCO
Direct Flow Medical said today that it landed a $32 million funding round for its replacement heart valve technology and tapped a 25-year medical device veteran, Chris Richardson, to lead its commercialization program.
SV Life Sciences buys majority stake in Ximedica
Ximedica said today that SV Life Sciences picked up a majority interest in the Providence, R.I.-based medical device development company from co-founders Stephen Lane and Aidan Petrie for an undisclosed amount.
CORRECTION: SafeStitch Medical issues shares in TransEnterix merger
Correction, Sept. 17, 2013: Due to a reporter’s error, this article originally stated that SafeStitch raised $160 million. The company instead issued $160 million worth of shares as part of its merger with TransEnterix.
Hansen Medical gets a new COO | Personnel Moves
Facebook IPO: Will it hurt medical device investment?
"How ‘ya gonna keep ’em down on the farm after they’ve seen Paree?"
Is Facebook really worth two Medtronics (NYSE:MDT)?
Health care law: A year in, doubts persist
MASSDEVICE ON CALL — One year into health care reform, sharp divides remain among Americans about the law along partisan lines, with half of the public unsure about its effects.
Fifty-two percent of Americans say they’re unsure about how the law will affect them, according to a survey of "a nationally representative random sample of 1,202 adults ages 18 and older" conducted by the Kaiser Family Foundation.
Top device VC: Fix FDA or watch business go to Costa Rica
A Boston, Mass.-based venture capitalist and former Boston Scientific Corp. (NYSE:BSX) executive is adding his voice to the chorus of medical device stakeholders calling for an overhaul to the way the FDA regulates medical devices.
